EFGCP Annual Conference on 26-27 January 2010 in Brussels
Jean-Pierre Tassignon will open the conference and provide closing remarks. The conference is about ‘The impact of personalized medicine on society: how to tackle the new challenges’. Link
EFGCP Multidisciplinary Workshop on 7 July 2009, Diamant Center, Brussels
This conference is about ‘A single CTA in multinational clinical trials: dream or option?’. Jean-Pierre Tassignon will co-chair the session on how a single CTA could affect Research Ethics Committee procedures.
The European Forum for GCP organizes a conference in Prague in January 2009 about Research Misconduct: A European Perspective. Jean-Pierre Tassignon, President & CEO of Crossover and Chairman of the EFGCP will give an introduction and make closing remarks. Link
BPCM academic meeting on 16 January 2009 in Brussels. Jean-Pierre Tassignon, who is a Fellow of the Belgian College of Pharmaceutical Medicine, will attend this meeting.
ECRIN Network Development Board meeting on 7 January, 2009 in Brussels. Jean-Pierre Tassignon, who is a member of the NDB on behalf of the EFGCP will attend this meeting.
BeAPP lunch on 18 Nov 2008 in Brussels
Jean-Pierre Tassignon will attend the monthly lunch of the Belgian Association of Pharmaceutical Physicians, of which he is a new member. The venue is UCB’s pharma headquarters in Brussels. Link
ECRIN Network Committee, Budapest, Hungary
Jean-Pierre Tassignon, Chairman of the EFGCP and President of Crossover CRI AG, will attend the Network Committee meeting of ECRIN in Budapest, Hungary. Link
A Workshop on Clinical Research in Kyrgyzstan and Central Asia
was held in Bishkek, sponsored by the Ministry of Health of the Kyrgyz Republic, the EFGCP in Brussels and the United Nations office in Byshkek. Jean-Pierre Tassignon was invited by the Ministry of Health of Kyrgyzstan to lecture before the medical establishment of central hospitals in Bishkek about the organization of clinical research in Europe. Dr Tassignon, who represented the EFGCP, lectured on the clinical research infrastructure in the EU, emphasizing that three decades of developing standards, laws and regulations, institutions, education and training and the financing of clinical trials have turned the EU into one of the prime drug development regions of the world immediately after the USA. On the 2nd day, he facilitated a workshop on whether Clinical Research Units would have merit at central hospitals in Kyrgyzstan, and another workshop on the establishment of a Central Asian Forum for GCP on the model of the EFGCP.
ECRIN Network Committee and International Clinical Trials Day, Brussels, Belgium. Jean-Pierre Tassignon, Chairman of the EFGCP and President of Crossover CRI AG, will attend the Network Committee meeting of ECRIN at the Résidence Palace in Brussels, including the International Clinical Trials Day on the 20th. The ICTD – which was first celebrated in 2005 – will be marked throughout Europe with events and communications about the fundamental requirement for more and better clinical research relevant to the needs of patients. Link